Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Neurol ; 95(6): 1058-1068, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38466157

RESUMO

OBJECTIVE: Along with the known effects of stress on brain structure and inflammatory processes, increasing evidence suggest a role of chronic stress in the pathogenesis of Alzheimer's disease (AD). We investigated the association of accumulated stressful life events (SLEs) with AD pathologies, neuroinflammation, and gray matter (GM) volume among cognitively unimpaired (CU) individuals at heightened risk of AD. METHODS: This cross-sectional cohort study included 1,290 CU participants (aged 48-77) from the ALFA cohort with SLE, lumbar puncture (n = 393), and/or structural magnetic resonance imaging (n = 1,234) assessments. Using multiple regression analyses, we examined the associations of total SLEs with cerebrospinal fluid (1) phosphorylated (p)-tau181 and Aß1-42/1-40 ratio, (2) interleukin 6 (IL-6), and (3) GM volumes voxel-wise. Further, we performed stratified and interaction analyses with sex, history of psychiatric disease, and evaluated SLEs during specific life periods. RESULTS: Within the whole sample, only childhood and midlife SLEs, but not total SLEs, were associated with AD pathophysiology and neuroinflammation. Among those with a history of psychiatric disease SLEs were associated with higher p-tau181 and IL-6. Participants with history of psychiatric disease and men, showed lower Aß1-42/1-40 with higher SLEs. Participants with history of psychiatric disease and women showed reduced GM volumes in somatic regions and prefrontal and limbic regions, respectively. INTERPRETATION: We did not find evidence supporting the association of total SLEs with AD, neuroinflammation, and atrophy pathways. Instead, the associations appear to be contingent on events occurring during early and midlife, sex and history of psychiatric disease. ANN NEUROL 2024;95:1058-1068.


Assuntos
Doença de Alzheimer , Peptídeos beta-Amiloides , Encéfalo , Doenças Neuroinflamatórias , Proteínas tau , Humanos , Doença de Alzheimer/patologia , Doença de Alzheimer/diagnóstico por imagem , Feminino , Masculino , Idoso , Pessoa de Meia-Idade , Estudos Transversais , Estudos de Coortes , Encéfalo/patologia , Encéfalo/diagnóstico por imagem , Doenças Neuroinflamatórias/patologia , Doenças Neuroinflamatórias/diagnóstico por imagem , Peptídeos beta-Amiloides/líquido cefalorraquidiano , Peptídeos beta-Amiloides/metabolismo , Proteínas tau/líquido cefalorraquidiano , Imageamento por Ressonância Magnética , Estresse Psicológico , Substância Cinzenta/patologia , Substância Cinzenta/diagnóstico por imagem , Interleucina-6/líquido cefalorraquidiano , Fragmentos de Peptídeos/líquido cefalorraquidiano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...